Eco R1 Capital, LLC Gamida Cell Ltd. Transaction History

Eco R1 Capital, LLC

  • $2.83 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$3.0 - $5.09 $156,360 - $265,290
-52,120 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$4.98 - $11.32 $259,557 - $589,998
52,120 New
52,120 $265,000

Others Institutions Holding GMDA

# of Institutions
2
Shares Held
31.4K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email